Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061540) titled 'A Retrospective Study of the Relationship Between Chest Tube Placement and Pleurodesis Success' on May 12.
Study Type:
Observational
Primary Sponsor:
Institute - Hyogo Cancer Center
Condition:
Condition - Malignant pleural effision
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the impact of chest tube placement on pleurodesis success in patients with malignant pleural effusion.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - The patients who underwent talc slurry-based pleurodesis for malignant pleural effusion between April 2015 and December 2024.
Key exclusion criteria - Patients were excluded if they: (1) had previously undergone chemical pleurodesis on the ipsilateral thorax; (2) underwent prophylactic pleurodesis (it means they were asymptomatic and had pleural fluid confined below the dome of the diaphragm); (3) had a radiologically significant (>25%) non-expandable lung; (4) did not undergo lateral chest X-ray assessment, and therefore the chest tube position was unknown; (5) developed empyema during the treatment; (6) underwent repeat pleurodesis before the chest tube removal; (7) did not undergo any radiological assessment beyond 1 week after pleurodesis.
Target Size - 200
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 09 Month 01 Day
Date of IRB - 2025 Year 09 Month 11 Day
Anticipated trial start date - 2025 Year 09 Month 11 Day
Last follow-up date - 2026 Year 04 Month 01 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070418
Disclaimer: Curated by HT Syndication.
